7.35.4 NMAC · Treatment Equity Fund

Meetings, filings, and documents ยท newest first

Meetings and filings

The dated chain of the treatment equity fund rulemaking: the committee's threshold vote, its framework vote, the board's vote, the proposed rule, and the hearing on it, each with the documents it produced and the documents this site does not hold. The committee and board meetings are cited to the department's recordings.

Created October 22, 2026.

The chain

Every meeting, publication, and scheduled date is one event with its own address, so another page can cite the day rather than restate it. The committee and board meetings are cited to the department's recordings at the moment quoted; the captions are automatic and carry no speaker labels.

NOV 202026Scheduled

The rule hearing on the proposed 7.35.4 NMAC and the proposed amendment to 7.35.2.7 NMAC, 9:00 AM, Harold Runnels Building auditorium, 1190 St. Francis Drive, Santa Fe, in person, by video conference, and by telephone. Fixed by the notice published October 20. Written comment must be received by the close of the hearing.

OCT 202026Document

The department published the proposed 7.35.4 NMAC, Treatment Equity Fund, with a proposed amendment to the definitions at 7.35.2.7 NMAC and the notice of the November 20 hearing on both.

What changed

  • A new Part. Twenty sections; the first published text of the rule the Medical Psilocybin Act, Section 26-2D-11, leaves to the department. The proposed rule
  • Against the board vote. Two preparatory or integrative sessions per later administration where the board voted three; the diagnostic evaluation and the cost of medication not named among allowable expenses. The board recommendation

Attached

The account in full

SEP 112026Meeting

The Medical Psilocybin Advisory Board voted 7-0 to recommend the equity fund framework from the Equity, Access and Cultural Considerations Committee, with three preparatory or integrative sessions for each additional administration session in place of the committee's two. The department read the framework as an outline of intent; the HCA delegate asked that the payer of last resort language be settled by the attorneys. Source: the department's recording, automatic captions without speaker labels.

Who said what

From the automatic captions of the department's recording. The captions carry no speaker labels; a name is given only where a speaker names themself or is addressed by name.

  • The department, reading the outline: coverage "for individuals who are at or below 200% of the poverty level", the "diagnostic evaluation" and "any of the medical evaluations", "6 preparatory or integration sessions with an administration session", and two more per additional administration. 0:43:40 to 0:44:55
  • A speaker addressed as Chris: "I initially said two, but I might bump it up to three." 0:45:49
  • "But this is Larry. I like 3. I would support three." 0:49:55
  • A speaker called on as Keenan: "specifically saying you have to bill Medicaid first might get you into some legal trouble." The department: "our attorneys are already working on that specific language." 0:50:21, 0:51:46
  • The department: "the cost of medication", travel "if the patient resides more than 100 miles", reimbursements not exceeding "the rates for Medicaid reimbursement", audit procedures, the ability "to hold or suspend payments", and New Mexico residency. 0:52:43 to 0:54:04
  • On provider travel to a homebound patient: "That's not a part of this proposal." 0:54:32
  • The motion: "to have a vote on the three. And after the first administration and for the first administration, 6 sessions of either prep and integration along with the equity fund tapering off to 200%." 1:01:53
  • "seven in support"; "any no votes. I see none from the board members." 1:03:08, 1:03:26

Attached

The account in full

AUG 182026Meeting

The Equity, Access and Cultural Considerations Committee voted 5-0 to send an equity fund framework to the Advisory Board: 200 percent of the federal poverty level, the diagnostic evaluation, six preparatory or integrative sessions, up to three administration days with two more sessions for each additional day, the cost of medication, travel beyond 100 miles, the fund as last payer, a Medicaid rate cap, audit and hold or suspend clauses, and New Mexico residency. Source: the department's recording, automatic captions without speaker labels.

Who said what

From the automatic captions of the department's recording, held at source-text/recordings/2026-08-18-eacc-BkJgUrcFk50.txt. The captions carry no speaker labels.

  • The read-out put to the vote: "individuals at or below 200% of the poverty level items that would be covered are diagnostic evaluation up to six preparatory and or integrative sessions, administration day up to three administrations, cost of the medication, travel if patient resides more than 100 miles". 1:03:57
  • The addendum: "up to three administration days with an additional two preparatory integrative" sessions. 1:10:22
  • On distance: "based on the travel distance. So, not necessarily straight as the crow flies." 1:09:53
  • A hardship application for a patient "far off a road" without a car was suggested and not put into the read-out. 1:09:01
  • Department discretion "to ensure the intent of the fund and its geographic" reach was suggested and not put into the read-out. 0:54:28
  • "looks like we have five people"; "There are zero no votes." 1:11:33, 1:12:33

Attached

The account in full

JUL 212026Meeting

The Equity, Access and Cultural Considerations Committee adopted 200 percent of the federal poverty level as the starting income threshold for the fund, by a show of hands: "we have adopted so far that 200% is a starting point" (1:14:38). Automatic qualification of Medicaid recipients was raised and set aside without a vote (1:54:08). Source: the department's recording, automatic captions without speaker labels.

JUN 202025Document

The Medical Psilocybin Act took effect. Section 26-2D-11 creates the medical psilocybin treatment equity fund, a nonreverting fund administered by the department, for treatment of qualified patients who meet income requirements set by department rule; the proposed 7.35.4.3 cites it.

Attached

Document register

Every document this site holds for this Part, what it is, when it landed, and whether it is current. The date in each row opens the event the document belongs to.

DocumentDateWhat it isStatusNotes
The proposed rule, 7.35.4 NMACrules-7.35.4-proposed-2026-10-20-published.pdf October 20, 2026 Treatment Equity Fund as proposed by the department: eligibility, the application, reimbursement and claims, allowable expenses, records, audits, denial and suspension, overpayments, monitoring, and administrative review. Proposed, not adopted; the text this site cites for section numbers and rule text Current 7 pages. Sections 7.35.4.1 through .20, typeset on this site at The proposed rule; every history note reads N, xx/xx/2026
Proposed amendment to 7.35.2.7 NMAC, the definitionsrules-7.35.2-amendments-2026-10-20-published.pdf October 20, 2026 Strike-and-add text for the definitions section of the producer and laboratory rule, which 7.35.4.7 imports. Proposed, not adopted; heard November 20 Record 5 pages. Carries the terms of the August 25 amendment and adds eleven for the fund: allowable amount, claim, claimant, covered treatment, director, federal poverty guidelines, fund, household, other payer, program manager, and SHARE
Notice of the November 20 rule hearinghearing-notice-7.35.4-2026-10-20.pdf October 20, 2026 The notice fixing the rule hearing on the proposed 7.35.4 NMAC and the proposed amendment to 7.35.2.7 NMAC for November 20, 2026, and stating the legal authority and how to comment Record 2 pages. It carries the video conference code, the telephone number, the written comment address, and the deadline: the close of the hearing
The Medical Psilocybin Actmedical-psilocybin-act-sb219-2025.pdf June 20, 2025 The enabling statute, Laws 2025, Chapter 73. Section 26-2D-11 creates the treatment equity fund, for treatment of qualified patients who meet income requirements set by department rule; the proposed rule cites it with 26-2D-7 Record 18 pages, the enrolled bill. The fund is bill Section 11, compiled as 26-2D-11

Documents this site does not hold

Named here so the gaps are visible rather than silent, each beside the event it belongs to.

DocumentWhat its absence meansThe event it belongs toStatus
The written equity fund recommendation On August 18 the department said it would write the committee's framework in formal language for the board; on September 11 it read an outline into the meeting and put it in the meeting chat. No written recommendation is posted. The recommendation on this site is taken from the recordings September 11 and August 18, 2026 Absent
Provenance: the source document and this page’s revisions▸

The document this page is read from

October 20, 2026

The proposed rule, 7.35.4 NMACCurrent state of truth

The proposed rule, published by the department on October 20, 2026: twenty sections setting patient eligibility for the medical psilocybin treatment equity fund, the application, reimbursement and claims, allowable expenses and travel, records, audits, payment denial and suspension, overpayments, program monitoring, and administrative review. It is the first published text of this Part, and it is proposed, not in effect; the rule hearing is November 20, 2026.

This document supersedes 0 earlier ones. Each of them, what it is, what superseded it and when, and a download, is in the register at Meetings and filings.

Revisions to this page

  • October 22, 2026 Created: the dated chain from the committee's July 21 threshold vote through the November 20 hearing, and the register, generated by tools/sync-record.py.